CSIMarket
 


Chemed Corporation  (CHE)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

CHE's Operating Income Growth by Quarter and Year

Chemed's Operating Income results by quarter and year




CHE Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 111.39 81.33 116.59 74.31
III Quarter September 86.85 80.86 71.70 92.76
II Quarter June 69.51 91.94 80.44 79.36
I Quarter March 72.82 89.37 143.25 77.45
FY   340.57 343.50 411.98 323.88



CHE Operating Income fourth quarter 2023 Y/Y Growth Comment
Chemed Corporation achieved in the fourth quarter 2023, above Company average Operating Income growth of 36.97% year on year, to $ 111.39 millions.

Looking into fourth quarter 2023 results within Healthcare Facilities industry 10 other companies have achieved higher Operating Income growth. While Chemed Corporation' s Operating Income rise of 36.97% ranks overall at the positon no. 927 in the fourth quarter 2023.

Explain Operating Income growth


CHE Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December 36.97 % -30.24 % 56.9 % 14.45 %
III Quarter September 7.41 % 12.78 % -22.7 % 41.55 %
II Quarter June -24.4 % 14.3 % 1.36 % 60.42 %
I Quarter March -18.52 % -37.61 % 84.96 % 14.95 %
FY   -0.85 % -16.62 % 27.2 % 30.96 %

Financial Statements
Chemed's fourth quarter 2023 Operating Income $ 111.39 millions CHE's Income Statement
Chemed's fourth quarter 2022 Operating Income $ 81.33 millions Quarterly CHE's Income Statement
New: More CHE's historic Operating Income Growth >>


CHE Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December 28.26 % 0.58 % 62.61 % -19.89 %
III Quarter September 24.95 % -12.05 % -10.87 % 16.89 %
II Quarter June -4.55 % 2.88 % -43.85 % 2.47 %
I Quarter March -10.46 % -23.35 % 92.77 % 19.28 %
FY (Year on Year)   -0.85 % -16.62 % 27.2 % 30.96 %




Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #11
Healthcare Sector #70
Overall #927

Operating Income Y/Y Growth Statistics
High Average Low
97.62 % 11.63 % -29.46 %
(Dec 31 2018)   (Dec 31 2017)
Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #11
Healthcare Sector #70
Overall #927
Operating Income Y/Y Growth Statistics
High Average Low
97.62 % 11.63 % -29.46 %
(Dec 31 2018)   (Dec 31 2017)

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Chemed's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
92.78 % 3.33 % -43.85 %
(Dec 31 2020)  


CHE's IV. Quarter Q/Q Operating Income Comment
Chemed Corporation achieved in the IV. Quarter 2023 above company average sequential Operating Income jump of 28.26%, to $ 111.39 millions, from $86.85 millions in the third quarter.
CHE is undergoing a remarkable growth, not only reporting higher then regular increase, and additionally increasing rate.

Within Healthcare Facilities industry 4 other companies have achieved higher Operating Income quarter on quarter growth. While Chemed's Operating Income growth quarter on quarter, overall rank is 328.


Operating Income Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #5
Healthcare Sector #29
Overall #328
Operating Income Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #5
Healthcare Sector #29
Overall #328
Operating Income Q/Q Growth Statistics
High Average Low
92.78 % 3.33 % -43.85 %
(Dec 31 2020)  


CHE's IV. Quarter Q/Q Operating Income Comment
Chemed Corporation achieved in the IV. Quarter 2023 above company average sequential Operating Income jump of 28.26%, to $ 111.39 millions, from $86.85 millions in the third quarter.
Chemed is undergoing a remarkable growth, not just reporting higher then average growth, and additionally improving speed.

Within Healthcare Facilities industry 4 other companies have achieved higher Operating Income quarter on quarter growth. While Chemed's Operating Income growth quarter on quarter, overall rank is 328.


Chemed's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Operating Income 12 Months Ending $ 340.57 $ 310.50 $ 304.51 $ 326.94 $ 343.50
Y / Y Operating Income Growth (TTM) -0.85 % -18.02 % -17.61 % -8.7 % -16.62 %
Year on Year Operating Income Growth Overall Ranking # 1032 # 1107 # 481 # 790 # 625
Seqeuential Operating Income Change (TTM) 9.68 % 1.97 % -6.86 % -4.82 % -9.31 %
Seq. Operating Income Growth (TTM) Overall Ranking # 927 # 1109 # 402 # 868 # 918




Cumulative Operating Income growth Comment
Chemed showed decline, but improvement compare to trailing twelve month Operating Income decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Chemed's annual Operating Income decrease would be -0.85% year on year to $341 millions.

In the Healthcare sector 80 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 1032, from total ranking in previous quarter at 1107.

Operating Income TTM Q/Q Growth Statistics
High Average Low
97.62 %
11.63 %
-29.46 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 11
Healthcare Sector # 81
Overall # 1032

Operating Income TTM Y/Y Growth Statistics
High Average Low
97.62 %
11.63 %
-29.46 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 11
Sector # 70
S&P 500 # 927
Cumulative Operating Income growth Comment
Chemed showed decline, but improvement compare to trailing twelve month Operating Income decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Chemed's annual Operating Income drop would be -0.85% year on year to $341 millions.

In the Healthcare sector 80 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 1032, from total ranking in previous quarter at 1107.

Operating Income TTM Q/Q Growth Statistics
High Average Low
97.62 %
11.63 %
-29.46 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 11
Healthcare Sector # 81
Overall # 1032

Operating Income TTM Y/Y Growth Statistics
High Average Low
97.62 %
11.63 %
-29.46 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 11
Sector # 70
S&P 500 # 927




Other Operating Income Growth
Healthcare Facilities Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
CHE's Operating Income Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for CHE's Competitors
Operating Income Growth for Chemed's Suppliers
Operating Income Growth for CHE's Customers

You may also want to know
CHE's Annual Growth Rates CHE's Profitability Ratios CHE's Asset Turnover Ratio CHE's Dividend Growth
CHE's Roe CHE's Valuation Ratios CHE's Financial Strength Ratios CHE's Dividend Payout Ratio
CHE's Roa CHE's Inventory Turnover Ratio CHE's Growth Rates CHE's Dividend Comparisons



Companies with similar Operating Income drop for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2023
Dariohealth Corp 57.77%$ 57.769 millions
Alcon inc 54.61%$ 54.613 millions
Stryker Corp54.42%$ 54.423 millions
Align Technology inc 52.27%$ 52.267 millions
Davita Inc 52.16%$ 52.158 millions
Healthcare Services Group Inc 51.40%$ 51.399 millions
Tactile Systems Technology Inc 50.32%$ 50.318 millions
Viemed Healthcare Inc 49.66%$ 49.660 millions
United Therapeutics Corporation48.12%$ 48.121 millions
Lemaitre Vascular Inc 46.49%$ 46.491 millions
Neurocrine Biosciences Inc 45.36%$ 45.358 millions
Boston Scientific Corporation45.27%$ 45.274 millions
Msa Safety Incorporated44.79%$ 44.789 millions
Corcept Therapeutics Inc40.76%$ 40.757 millions
Powerup Acquisition Corp 39.00%$ 38.999 millions
Tenet Healthcare Corp37.13%$ 37.127 millions
Chemed Corporation36.97%$ 36.971 millions
Abbott Laboratories36.50%$ 36.503 millions
Nature s Sunshine Products inc 36.49%$ 36.490 millions
Halozyme Therapeutics Inc 35.60%$ 35.601 millions
Catalyst Pharmaceuticals Inc 35.36%$ 35.359 millions
Iqvia Holdings Inc 32.19%$ 32.190 millions
Select Medical Holdings Corp31.53%$ 31.531 millions
Tenax Therapeutics Inc 30.78%$ 30.780 millions
Alpha Pro Tech Ltd 27.93%$ 27.931 millions
West Pharmaceutical Services Inc 24.06%$ 24.056 millions
Option Care Health Inc 24.00%$ 23.997 millions
Infusystem Holdings Inc 21.48%$ 21.477 millions
Intuitive Surgical Inc 20.86%$ 20.859 millions
Bionomics Limited20.74%$ 20.739 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com